Company Announcements

On October 15, Bernd Brust resigned as president of Molecular Medicine at Life Technologies.

Illumina named Dr. Daniel S. Grosu, MD, to the newly created position of vice president and chief medical officer in late October. He was previously group director, Clinical Science, Clinical and Medical Affairs at Ortho-Clinical Diagnostics.

On October 31, Xylem completed its spin-off from ITT and began operations as a $3.2 billion water technology firm (see IBO 1/15/11). On November 1, the company’s shares began trading on the New York Stock Exchange.

Bio-Rad Laboratories named Deborah J. Neff, president and CEO of Pathwork Diagnostics, to its Board in November.

Becton, Dickinson and Company announced in November that it named Alberto Mas president of BD Biosciences. He will also be responsible for the Cell Analysis and Labware units. He previously served as president of the Medical Surgical Systems business. Bill Rhodes, former president of BD Biosciences, was named senior vice president, Corporate Strategy and Development.

In November, JEOL announced that it will open a technical center in Thailand in January 2012. The center will be used as a base to provide technical support to researchers in Southeast Asia and India.

Halma named Daniela Barone Soares to its Board in November. She is chief executive of Impetus Trust.

Waters in November joined Mars and the US Agency for International Development in jointly pledging $1 million to create the Global Food Safety Capacity Building fund, which will be managed by the World Bank.

Waters named the Future Fuels Institute at Florida State University, Tallahassee, Florida, as a Center of Innovation, and the first Center in the field of energy research.

Shimadzu’s Analytical & Measuring Instruments sales for the fiscal half year ending September 30 grew 12.6% to ¥70.0 million ($879.1 million) (see IBO 11/15/11). Sales for General Analytical Instruments, Environmental Monitors, Testing Machines & Non-Destructive Inspection Machines, and Other rose 13.6%, 0.3%, 15.4% and 18.6% to make up 62%, 6%, 10%, and 15% of segment sales, respectively. Surface Analyzers sales declined 1.2% to make up 5% of segment sales. Within General Analytical Instruments, Chromatography sales rose 16.4% to ¥32.9 billion ($413.2 million). For fiscal 2012, the company forecasts Analytical & Measuring Instruments sales to increase 8.3% to ¥152.5 billion ($1,915 million). The company plans to build its fifth Chinese analysis center for the business in Chengdu, China, that will help develop new markets in inland regions. A new sales base in Zhengzhou, China, is also planned and will be Shimadzu’s 13th sales branch in China.

Diploma Life Sciences’ sales grew 34.3% in fiscal 2011 to £74.4 million ($120.0 million) (see IBO 12/15/11). Sales for the a1-group increased 7%, with a-1 envirosciences sales flat and CBISS revenue up 20%.